Sec Form 13G Filing - Werner Capital LLC filing for Enfusion Inc. (ENFN) - 2024-02-14

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549

 

 

 

SCHEDULE 13G

 

UNDER THE SECURITIES AND EXCHANGE ACT OF 1934

(Amendment No. 1)*

 

 

 

Enfusion, Inc. 

(Name of Issuer)

 

Class A common stock 

(Title of Class of Securities)

 

292812104 

(CUSIP Number)

 

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

 

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨Rule 13d-1(b)

 

¨Rule 13d-1(c)

 

xRule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

SCHEDULE 13G

 

CUSIP No. 292812104  

 

1

NAME OF REPORTING PERSONS

 

Werner Capital LLC

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  ¨

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY  
OWNED BY
EACH
REPORTING
PERSON
WITH
5

SOLE VOTING POWER

 

4,682,016 (1)

6

SHARED VOTING POWER

 

0

7

SOLE DISPOSITIVE POWER

 

4,682,016 (1)

8

SHARED DISPOSITIVE POWER

 

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

4,682,016 (1)

10

CHECK BOX IF THE AGGREGATE AMOU NT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

5.04% (2)

12

TYPE OF REPORTING PERSON

 

OO

 

(1) Consists of 4,682,016 shares of Class A Common Stock that Werner Capital LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.
   
(2) This percentage is based on 92,961,626 shares of Class A Common Stock outstanding, which is the sum of (i) 88,279,610 shares of Class A Common Stock outstanding as of November 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 7, 2023, and (ii) 4,682,016 shares of Class A Common Stock that Werner Capital LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Act.

 

 

 

 

1

NAME OF REPORTING PERSONS

 

Scott Werner

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  ¨

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America

NUMBER OF
SHARES
BENEFICIALLY  
OWNED BY
EACH
REPORTING
PERSON
WITH
5

SOLE VOTING POWER

 

4,685,903 (1)

6

SHARED VOTING POWER

 

0

7

SOLE DISPOSITIVE POWER

 

4,685,903 (1)

8

SHARED DISPOSITIVE POWER

 

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

4,685,903 (1)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

5.04% (2)

12

TYPE OF REPORTING PERSON

 

IN

 

(1) Consists of (i) 4,682,016 shares of Class A Common Stock that Werner Capital LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC and (ii) 3,887 shares of Class A Common Stock issuable to Scott Werner upon vesting of restricted stock units within 60 days of December 31, 2023.
   
(2) This percentage is based on 92,965,513 shares of Class A Common Stock outstanding, which is the sum of (i) 88,279,610 shares of Class A Common Stock outstanding as of November 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 7, 2023, (ii) 4,682,016 shares of Class A Common Stock that Werner Capital LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, and (iii) 3,887 shares of Class A Common Stock issuable to Scott Werner upon vesting of restricted stock units within 60 days of December 31, 2023. The shares represented by (ii) and (iii) have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Act.

 

 

 

 

Item 1

 

(a)Name of Issuer:

 

Enfusion, Inc.

 

(b)Address of Issuer’s Principal Executive Offices:

 

125 South Clark Street, Suite 750, Chicago, Illinois 60603

 

Item 2

 

(a)Name of Person Filing:

 

This statement is filed by Werner Capital LLC and Scott Werner (together, the “Reporting Persons”). Mr. Werner is the sole manager of Werner Capital LLC and may be deemed the beneficial owner of the shares held by Werner Capital LLC.

 

(b)Address of Principal Business Office or, if None, Residence:

 

c/o Enfusion, Inc.

 

125 South Clark Street, Suite 750, Chicago, Illinois 60603

 

(c)Citizenship:

 

Werner Capital LLC is a Delaware limited liability company and Scott Werner is a citizen of the United States of America.

 

(d)Title of Class of Securities:

 

Class A common stock, par value $0.001 per share

 

(e)CUSIP Number:

 

292812104

 

Item 3If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)  ¨Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
     
(b)  ¨Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
     
(c)  ¨Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
     
(d)  ¨Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
     
(e)  ¨An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
     
(f)  ¨An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
     
(g)  ¨A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
     
(h)  ¨A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
     
(i)  ¨A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
     
(j)  ¨A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
     
(k)  ¨Group, in accordance with §240.13d-1(b)(1)(ii)(K).

  

Item 4Ownership.

 

I.Werner Capital LLC

 

(a) Amount beneficially owned: 4,682,016 (1)
(b) Percent of class: 5.04% (3)
(c) Number of shares as to which such person has:

 

 

 

 

(i)Sole power to vote or direct the vote: 4,682,016 (1)
(ii)Shared power to vote or direct the vote: 0
(iii)Sole power to dispose or direct the disposition: 4,682,016 (1)
(iv)Shared power to dispose or direct the disposition: 0

 

II.Scott Werner

 

(a) Amount beneficially owned: 4,685,903 (1)(2)
(b) Percent of class: 5.04% (4)
(c) Number of shares as to which such person has:

(i)Sole power to vote or direct the vote: 4,685,903 (1)(2)
(ii)Shared power to vote or direct the vote: 0
(iii)Sole power to dispose or direct the disposition: 4,685,903 (1)(2)
(iv)Shared power to dispose or direct the disposition: 0

 

  (1) Includes 4,682,016 shares of Class A Common Stock that Werner Capital LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.  
     
  (2) Includes 3,887 shares of Class A Common Stock issuable to Scott Werner upon vesting of restricted stock units within 60 days of December 31, 2023.
     
  (3) This percentage is based on 92,961,626 shares of Class A Common Stock outstanding, which is the sum of (i) 88,279,610 shares of Class A Common Stock outstanding as of November 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 7, 2023, and (ii) 4,682,016 shares of Class A Common Stock that Werner Capital LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Act.
     
  (4) This percentage is based on 92,965,513 shares of Class A Common Stock outstanding, which is the sum of (i) 88,279,610 shares of Class A Common Stock outstanding as of November 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 7, 2023, (ii) 4,682,016 shares of Class A Common Stock that Werner Capital LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, and (iii) 3,887 shares of Class A Common Stock issuable to Scott Werner upon vesting of restricted stock units within 60 days of December 31, 2023. The shares represented by (ii) and (iii) have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Act.

 

Item 5Ownership of Five Percent or Less of a Class.

 

Not applicable.

 

Item 6Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable.

 

Item 7Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

 

Not applicable.

 

 

 

 

Item 8Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9Notice of Dissolution of Group.

 

Not applicable.

 

Item 10Certification.

 

Not applicable.

 

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: February 14, 2024

 

  Werner Capital LLC
   
  By: /s/  Scott Werner
    Name: Scott Werner
Title: Sole Manager
     
  By: /s/  Scott Werner
    Scott Werner

 

 

 

 

EXHIBIT INDEX

 

Exhibit
No.
  Description
99.1   Joint Filing Agreement, dated as of February 16, 2022 (incorporated by reference to Exhibit 99.1 of the Schedule 13G filed by the Reporting Persons on February 16, 2022).